These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14972566)

  • 61. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?
    Rosas CT; Goodman LB; von Einem J; Osterrieder N
    Expert Rev Vaccines; 2006 Feb; 5(1):119-31. PubMed ID: 16451114
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunization with pseudorabies virus harboring Fc domain of IgG makes a contribution to protection of mice from lethal challenge.
    Takashima Y; Tsukamoto M; Ota H; Matsumoto Y; Hayashi Y; Otsuka H
    Vaccine; 2005 May; 23(29):3775-82. PubMed ID: 15893614
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine.
    Wu JQ; Barabé ND; Chau D; Wong C; Rayner GR; Hu WG; Nagata LP
    Vaccine; 2007 May; 25(22):4368-75. PubMed ID: 17467858
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein.
    Mota J; Acosta M; Argotte R; Figueroa R; Méndez A; Ramos C
    Vaccine; 2005 May; 23(26):3469-76. PubMed ID: 15837370
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.
    Xin KQ; Jounai N; Someya K; Honma K; Mizuguchi H; Naganawa S; Kitamura K; Hayakawa T; Saha S; Takeshita F; Okuda K; Honda M; Klinman DM; Okuda K
    Gene Ther; 2005 Dec; 12(24):1769-77. PubMed ID: 16079886
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potential of equine herpesvirus 1 as a vector for immunization.
    Trapp S; von Einem J; Hofmann H; Köstler J; Wild J; Wagner R; Beer M; Osterrieder N
    J Virol; 2005 May; 79(9):5445-54. PubMed ID: 15827159
    [TBL] [Abstract][Full Text] [Related]  

  • 67. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
    Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection.
    Holzer GW; Coulibaly S; Aichinger G; Savidis-Dacho H; Mayrhofer J; Brunner S; Schmid K; Kistner O; Aaskov JG; Falkner FG; Ehrlich H; Barrett PN; Kreil TR
    Vaccine; 2011 May; 29(24):4132-41. PubMed ID: 21477673
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A chimeric baculovirus displaying bovine herpesvirus-1 (BHV-1) glycoprotein D on its surface and their immunological properties.
    Peralta A; Molinari P; Conte-Grand D; Calamante G; Taboga O
    Appl Microbiol Biotechnol; 2007 May; 75(2):407-14. PubMed ID: 17285288
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review.
    Patel JR; Heldens J
    Vet J; 2005 Jul; 170(1):14-23. PubMed ID: 15993786
    [TBL] [Abstract][Full Text] [Related]  

  • 71. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
    Csellner H; Walker C; Wellington JE; McLure LE; Love DN; Whalley JM
    Arch Virol; 2000; 145(11):2371-85. PubMed ID: 11205124
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.
    Jiang Y; Xiao S; Fang L; Yu X; Song Y; Niu C; Chen H
    Vaccine; 2006 Apr; 24(15):2869-79. PubMed ID: 16446016
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K; Rani R; Vrati S
    Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Jan; 11(1):57-65. PubMed ID: 19006097
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes.
    Niesalla H; de Andrés X; Barbezange C; Fraisier C; Reina R; Arnarson H; Biescas E; Mazzei M; McNeilly TN; Liu C; Watkins C; Perez M; Carrozza ML; Bandecchi P; Solano C; Crespo H; Glaria I; Huard C; Shaw DJ; de Blas I; de Andrés D; Tolari F; Rosati S; Suzan-Monti M; Andrésdottir V; Torsteinsdottir S; Petursson G; Badiola J; Lujan L; Pepin M; Amorena B; Blacklaws B; Harkiss GD
    Vaccine; 2009 Jan; 27(2):260-9. PubMed ID: 18984025
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD.
    Zhang Y; Smith PM; Tarbet EB; Osterrieder N; Jennings SR; O'Callaghan DJ
    Virus Res; 1998 Jul; 56(1):11-24. PubMed ID: 9784062
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The pathogenesis of ED71, a defined deletion mutant of equine herpesvirus-1, in a murine intranasal infection model for equine abortion.
    Fitzmaurice T; Walker C; Kukreja A; Sun Y; Brown SM; Field HJ
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2167-9. PubMed ID: 9292003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.